ASPIRUS MEDICAL GROUP INC
Income Statement
Fiscal Year Start:
Jul 1
Revenues in 2024
$128,362,741
Program Services
>99%
Other
<1%
Contributions
<1%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Investments
0%
Expenses in 2024
$163,943,942
Salaries & Benefits
58%
Other
29%
Fees to Service Providers
8%
Offices, Occupancy & IT
3%
Depreciation
2%
Advertising & Promotion
<1%
Interest
<1%
Grants
0%
Benefits to Members
0%
Revenues
2023
2024
Change
Contributions
$0
$48,305
-
Government Grants
$233,387
$0
-100%
Fundraising Events
$0
$0
-
Program Services
$121,377,042
$128,196,428
+6%
Membership Dues
$0
$0
-
Investments
$0
$0
-
Other
$86,190
$118,008
+37%
Total Revenues
$121,696,619
$128,362,741
+5%
Expenses
2023
2024
Change
Grants
$0
$0
-
Benefits to Members
$0
$0
-
Salaries & Benefits
$94,040,913
$95,220,821
+1%
Fees to Service Providers
$11,744,746
$13,647,820
+16%
Advertising & Promotion
$9,953
$16,614
+67%
Offices, Occupancy & IT
$4,824,057
$4,788,418
-1%
Interest
$419
$225
-46%
Depreciation
$3,063,992
$3,537,665
+15%
Other
$45,447,564
$46,732,379
+3%
Total Expenses
$159,131,644
$163,943,942
+3%
Net income
2023
2024
Change
Net income
-$37,435,025
-$35,581,201
+5%
Functional Expenses
Summary
2023
2024
Change
Program
$141,805,300
$160,776,796
+13%
Admin
$17,326,344
$3,167,146
-82%
Fundraising
$0
$0
-
Total Expenses
$159,131,644
$163,943,942
+3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)